2023
DOI: 10.2217/epi-2023-0281
|View full text |Cite
|
Sign up to set email alerts
|

CRISPR-Based Epigenome Editing: Mechanisms and Applications

Shaima M Fadul,
Aleeza Arshad,
Rashid Mehmood

Abstract: Epigenomic anomalies contribute significantly to the development of numerous human disorders. The development of epigenetic research tools is essential for understanding how epigenetic marks contribute to gene expression. A gene-editing technique known as CRISPR (clustered regularly interspaced short palindromic repeats) typically targets a particular DNA sequence using a guide RNA (gRNA). CRISPR/Cas9 technology has been remodeled for epigenome editing by generating a ‘dead’ Cas9 protein (dCas9) that lacks nuc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 169 publications
0
1
0
Order By: Relevance
“…Even though the CRISPR-dCas9 system helps to improve the precision and specificity of gene editing, reported cases of off-target effects restrict their widespread application in clinical studies. Methods to mitigate these off-target effects have been developed, which could potentially advance the clinical use of CRISPR systems ( 122 , 124 , 125 ). Another limitation of using CRISPR-based epigenetic editing is the large size of CRISPR-Cas9 systems.…”
Section: Induction Of Tls: Current and Potential Strategiesmentioning
confidence: 99%
“…Even though the CRISPR-dCas9 system helps to improve the precision and specificity of gene editing, reported cases of off-target effects restrict their widespread application in clinical studies. Methods to mitigate these off-target effects have been developed, which could potentially advance the clinical use of CRISPR systems ( 122 , 124 , 125 ). Another limitation of using CRISPR-based epigenetic editing is the large size of CRISPR-Cas9 systems.…”
Section: Induction Of Tls: Current and Potential Strategiesmentioning
confidence: 99%